A patient was rushed into the operating room needing a life-saving abdominal operation. Shortly after, he was brought out of the operating room safe and recovering.
Mary Chiles General Hospital, with its team of expert surgeons, employed the new Covidien LigasureTM System to perform abdominal surgeries with minimal invasiveness. The Covidien LigasureTM System is a patented state-of-the-art family of medical devices which enhances the surgeon’s ability to stop a patient’s bleeding during an operation. The system enables surgeons to perform complex surgeries with minimal blood loss, less risks, and faster patient recovery. The system is for use with the ForceTriadTM energy platform controlled by TissueFectTM sensing technology which is all part of the cutting-edge Medtronic Minimally Invasive Therapies line. Medtronic, the developer of the Covidien LigasureTM System, is a US based company that is also a global leader in medical technology, services, and solutions.